Activation of PI3K /Akt pathway by G protein‐coupled receptor 37 promotes resistance to cisplatin‐induced apoptosis in non‐small cell lung cancer
Cancer Medicine · 2023-10 · 12 (19) · 19777-19793
DOI: 10.1002/cam4.6543 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 21.09.2023. Verfasst von Han Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, The First Hospital of Jilin University, Changchun, Jilin, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Lung cancer is a major public health concern and represents the most common cause of cancer‐related death worldwide. Among eukaryotes, the G protein‐coupled receptor ( GPCR ) family stands as the largest group of membrane proteins. Alterations in GPCR gene expression and dysregulation of signal transduction have been recognized as the markers of malignancy. As a member of the GPCR family, G protein‐coupled receptor 37 ( GPR37 ) exhibits unknown functions in tumors, particularly in non‐small‐cell lung cancer ( NSCLC )
Methods
We explored the expression and prognosis of GPR37 in NSCLC through TCGA, GTEx, GEO, and GEPIA2. We detected the expression of GPR37 in NSCLC tissues and cell lines. The study explored the influence of GPR37 on tumor cell proliferation. Furthermore, we examined the effects of GPR37 on tumor cell apoptosis and invasion. Most importantly, we investigated whether GPR37 affects cisplatin‐induced drug resistance in NSCLC. Furthermore, by conducting animal experiments, we assessed the impact of GPR37 on NSCLC and delved into underlying mechanisms.
Results
(1) In NSCLC, the expression of GPR37 is markedly higher than that in corresponding normal tissues. We found that elevated GPR37 expression predicts an unfavorable prognosis. (2) It was demonstrated that GPR37 positively regulates NSCLC cell invasion, migration, and proliferation, suppresses cell apoptosis, heightens resistance to cisplatin, and promotes tumor formation and growth. Conversely, we observed that GPR37 knockdown suppresses NSCLC cell invasion, migration, and proliferation, promotes cell apoptosis, increases sensitivity to cisplatin, and affects tumor formation and growth. (3) GPR37 activates PI3K/Akt/mTOR signal transduction pathways to mediate epithelial‐mesenchymal transition (EMT), thereby promoting the progression of NSCLC.
Conclusions
It was suggested that GPR37 acts a crucial role in promoting the occurrence and development of NSCLC. Knockdown of GPR37 significantly inhibits the occurrence and development of NSCLC. Therefore, our findings demonstrated that GPR37 may represent a viable therapeutic target for NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Medicine, The First Hospital of Jilin University, Changchun, Jilin, China.
- Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.
- Department of General Practice, The First Hospital of Jilin University, Changchun, Jilin, China.
- Department of Vascular Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, Jilin, China.
ORCID-Profile: Lei Song
Zitieren
APA
Liu, H., Zhu, Y., Niu, H., Jie, J., Hua, S., Bai, X., Wang, S., & Song, L. (2023). Activation of PI3K /Akt pathway by G protein‐coupled receptor 37 promotes resistance to cisplatin‐induced apoptosis in non‐small cell lung cancer. Cancer Medicine, 12(19), 19777-19793. https://doi.org/10.1002/cam4.6543
Vancouver
Liu H, Zhu Y, Niu H, Jie J, Hua S, Bai X, et al. Activation of PI3K /Akt pathway by G protein‐coupled receptor 37 promotes resistance to cisplatin‐induced apoptosis in non‐small cell lung cancer. Cancer Medicine. 2023;12(19):19777-19793. doi:10.1002/cam4.6543
BibTeX
@article{Liu2023,
author = {Liu, Han and Zhu, Yingjie and Niu, Huikun and Jie, Jing and Hua, Shucheng and Bai, Xiaoxue and Wang, Shuai and Song, Lei},
title = {Activation of PI3K /Akt pathway by G protein‐coupled receptor 37 promotes resistance to cisplatin‐induced apoptosis in non‐small cell lung cancer},
journal = {Cancer Medicine},
year = {2023},
volume = {12},
number = {19},
pages = {19777--19793},
doi = {10.1002/cam4.6543}
}
EUVIMED